Tom ntej: Retatrutide Peptide CAS 2381089-83-2
| Khoom npe | Retatrutide Peptide Hmoov |
| CAS Nr | 2592008-21-0 |
| Qhov tshwm sim | Dawb, sterile, lyophilized hmoov |
| Molecular Formula | C215H347N61O65 |
| Molecular Luj | 4,852.50 |
| Purity (HPLC) | Ntau dua lossis sib npaug li 99% (Tsev Tshuaj) |
| Txee lub neej | 24 lub hlis ( khaws cia ntawm -20 degree, tiv thaiv los ntawm lub teeb) |
| Kev kho dua tshiab | PBS tsis kam (pH 7.4) |
| Ntim | Lub raj mis kaw |
| Yam tsawg kawg nkaus Order Quantity | 1 g (ntau ntau muaj) |
Retatrutide Peptide 99%:Triple -Agonist Revolutionizing Metabolic Disease Treatment
-Global First GLP-1R/GIPR/GCGR Triple Agonist for Obesity, Diabetes, thiab NASH
Retatrutide Peptide Specifications
Retatrutide peptide hmoov yog ib qho hluavtaws 39-amino acid peptide engineered rau stability, multi-receptor affinity, thiab ncua ib nrab-lub neej. Nws cov qauv sib txuas cov ntsiab lus los ntawm GLP-1, GIP, thiab glucagon (GCG) los tsim ib qho triple agonist nrog optimized pharmacokinetics.
Retatrutide peptide sawv cev rau kev hloov pauv hloov pauv los ntawm kev sib koom ua ke ntawm peb qhov tseem ceeb receptors koom nrog hauv kev tswj cov piam thaj, tswj kev qab los noj mov, thiab kev siv hluav taws xob.
Yuav Ua Li Cas Retatrutide Peptide Ua Haujlwm
Retatrutide Peptide's triple agonism tsim ib qho kev sib koom ua ke uas hais txog kev rog rog, hyperglycemia, thiab daim siab rog ntau ntxiv:
GLP-1 Receptor Activation
- Stimulates insulin secretion los ntawm pancreatic -cov cell hauv cov piam thaj- nyob ntawm seb.
- inhibits glucagon tso tawm los ntawm -cells, txo cov piam thaj hauv siab.
- Ua kom lub plab zom mov qeeb, txhim kho satiety thiab txo cov khoom noj.
GIP Receptor Activation
- Txhim kho cov ntaub so ntswg adipose lipolysis, tso cov fatty acids dawb rau kev siv lub zog.
- Txhim kho insulin rhiab heev hauv cov leeg pob txha thiab daim siab, tiv thaiv insulin tsis kam.
- Txo cov hepatic triglyceride synthesis, txo cov roj siab hauv siab.
Ua kom GCGR
- Ua kom cov thermogenesis ntawm xim av adipose cov ntaub so ntswg, txhawb kev siv calorie.
- Txhawb glycogenolysis thiab lipolysis, txhawb nqa lub zog.
- Txo cov hepatic steatosis los ntawm inhibiting de novo lipogenesis.
Clinical Advantage: Thaum Semaglutide thiab Tirzepatide modulate 1-2 txoj hauv kev, Retatrutide Peptide's triple agonism ua tiav kev poob phaus, tswj glycemic, thiab daim siab rog txo los ntawm kev hais txog tag nrho peb lub ntsiab lus ntawm metabolic tsis ua haujlwm ib txhij.
Cov ntaub ntawv kho mob dab tsi qhia txog Retatrutide peptide
Poob Poob ntawm Retatrutide peptide Powder: Teem Cov Qauv Tshiab
Theem II Trial (N=338, 48 lub lis piam):
- 12 mg koob: 24.2% qhov hnyav poob qis (vs . 22.5% rau Tirzepatide thiab 16% rau Semaglutide).
- Ntau dua lossis sib npaug li 20% poob phaus: 63% ntawm cov neeg mob (vs . 50% rau Tirzepatide thiab 34% rau Semaglutide).
- Ntau dua lossis sib npaug li 30% poob phaus: 25% ntawm cov neeg mob (tsis tau pom dua hauv kev sim tshuaj tshuaj).
Glycemic Control ntawm Retatrutide peptide Powder: HbA1c Txo
Phase II sim (T2D Cov Neeg Mob, 36 lub lis piam):
- 12 mg koob: 2.5–3.0% txo HbA1c (vs. 1.5–2.0% rau Semaglutide thiab Tirzepatide).
- Kev Kho Mob Ntshav Qab Zib: 40% ntawm cov neeg mob ua tiav HbA1c<6.5% without medication.
Kev txo qis hauv siab ntawm Retatrutide peptide Powder: NASH Kev Kho Mob Muaj Peev Xwm
Theem II Kev sim (NAFLD Cov Neeg Mob, 24 lub lis piam):
- Cov ntsiab lus rog hauv siab: 86% txo (MRI- ntsuas PDFF) vs . 50–60% rau Semaglutide/Tirzepatide.
- ALT / AST theem: normalized nyob rau hauv 70% ntawm cov neeg mob, qhia tias txo daim siab mob.
Retatrutide peptide VS Tirzepatide VS Semaglutide
|
Kev sib piv |
Semaglutide |
Tirzepatide |
Retatrutide |
|
Mechanism ntawm Action |
Tib - lub hom phiaj: Ua rau GLP-1 receptor |
Dual -target: Ua kom GLP-1 + GIP receptors |
Triple -target: Ua kom GLP-1 + GIP + GCGR receptors |
|
Core Functions |
Txhawb nqa insulin secretion, inhibits glucagon, qeeb plab hnyuv |
Txhim kho insulin secretion, txhim kho insulin rhiab heev, txo cov kev mob tshwm sim GI |
Boosts metabolism (fat so + zog siv), ncaj qha hlawv rog, txo daim siab rog |
|
Poob Qhov Ua Tau Zoo |
15% -18% txo qhov nruab nrab (68 lub lis piam) |
18% -22.5% txo qhov nruab nrab (72 lub lis piam) |
24.2% txo qhov nruab nrab (48 lub lis piam; 63% ua tiav Ntau dua lossis sib npaug li 20% poob phaus) |
|
Kev txhim kho metabolic |
Txo HbA1c, txhim kho glycemic tswj |
Txo HbA1c, txo lub siab rog (zoo dua rau Semaglutide) |
86% daim siab txo qis (24 lub lis piam); 40% txo qis ntshav qab zib |
|
Kev ua lag luam Positioning |
Thawj -cov tshuaj poob phaus rau pob nyiaj- cov neeg mob tsis nco qab |
Hwm dual - lub hom phiaj kev xaiv rau cov neeg mob metabolic syndrome |
Qhov kawg poob phaus + metabolic breakthrough, yav tom ntej ua lag luam thawj coj |
Cov Lus Cim Tseem Ceeb:
Retatrutide Peptide's triple - lub hom phiaj tsim (GLP-1/GIP/GCGR) yog nws qhov zoo tshaj plaws, nrog GCGR ua kom ncaj qha txhawb kev rog rog.
Retatrutide Peptide cov ntaub ntawv 48-lub lim tiam ua tau zoo tshaj 72-lub lim tiam cov txiaj ntsig ntawm nws cov neeg sib tw, qhia tau sai thiab muaj zog dua.
Retatrutide Peptide Powderexcels hauv daim siab txo qis thiab txo cov ntshav qab zib, ua rau nws zoo tagnrho rau cov neeg mob NASH thiab metabolic syndrome.
Vim li cas thiaj xaiv Peb Retatrutide peptide Hmoov?
Quality Assurance:
Purity Ntau dua lossis sib npaug li 99%, endotoxin<0.1 EU/mg, and stability data (2-year shelf life at -20°C).
Txoj Cai Ua Raws Cai:
Thov COA, MSDS, DSC (cov ntaub ntawv qhia txog kev ruaj ntseg), thiab kev kuaj mob IDs (xws li, NCT tooj).
Logistics:
Peb cov kev pabcuam logistics lav kev nyab xeeb, kev xa khoom sai thoob ntiaj teb, thaum muab kev lis kev cai dual (DDP) nrog rau tag nrho cov se them ua ntej thiab qhov rooj-rau- qhov rooj yooj yim.
Customizable Formulations:
Cov tshuaj kho kom haum (1 mg–1 kg) rau R&D lossis siv coj mus muag.
Tiv tauj peb
Retatrutide peptide Powder redefines thaj chaw kho mob rau kev rog rog, ntshav qab zib, thiab NASH los ntawm kev sib koom ua ke GLP-1R, GIPR, thiab GCGR agonism rau hauv ib qho molecule. Nws qhov kev poob phaus tsis tau pom dua (24.2%), kev tswj hwm glycemic zoo dua, thiab txo qis hauv siab ua rau nws ua tus thawj coj hauv kev lag luam tshuaj metabolic $ 100 billion.
Rau cov lus nug ntau lossis cov qauv kev cai, hu rau peb pab neeg niaj hnub no kom ruaj ntseg koj cov khoom siv ntawm cov khoom siv tshuaj hloov pauv no.
Cim npe nrov: Tuam Tshoj Retatrutide Peptide CAS 2381089-83-2 Chaw tsim tshuaj paus, lwm tus neeg, Hoobkas
